A global review on short peptides: frontiers and perspectives

V Apostolopoulos, J Bojarska, TT Chai, S Elnagdy… - Molecules, 2021 - mdpi.com
Peptides are fragments of proteins that carry out biological functions. They act as signaling
entities via all domains of life and interfere with protein-protein interactions, which are …

Pathogenic mechanisms associated with different clinical courses of multiple sclerosis

H Lassmann - Frontiers in immunology, 2019 - frontiersin.org
In the majority of patients multiple sclerosis starts with a relapsing remitting course (RRMS),
which may at later times transform into secondary progressive disease (SPMS). In a minority …

CD38: an immunomodulatory molecule in inflammation and autoimmunity

ZL Piedra-Quintero, Z Wilson, P Nava… - Frontiers in …, 2020 - frontiersin.org
CD38 is a molecule that can act as an enzyme, with NAD-depleting and intracellular
signaling activity, or as a receptor with adhesive functions. CD38 can be found expressed …

The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells

J Machado-Santos, E Saji, AR Tröscher, M Paunovic… - Brain, 2018 - academic.oup.com
Multiple sclerosis is an inflammatory demyelinating disease in which active demyelination
and neurodegeneration are associated with lymphocyte infiltrates in the brain. However, so …

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

D Cadavid, M Mellion, R Hupperts… - The Lancet …, 2019 - thelancet.com
Background Opicinumab is a human monoclonal antibody against LINGO-1, an inhibitor of
oligodendrocyte differentiation and axonal regeneration. Previous findings suggested that …

A genetics-led approach defines the drug target landscape of 30 immune-related traits

H Fang, H De Wolf, B Knezevic, KL Burnham… - Nature …, 2019 - nature.com
Most candidate drugs currently fail later-stage clinical trials, largely due to poor prediction of
efficacy on early target selection. Drug targets with genetic support are more likely to be …

Extra-adrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders

RM Slominski, RC Tuckey, PR Manna, AM Jetten… - Genes & …, 2020 - nature.com
Glucocorticoid synthesis is a complex, multistep process that starts with cholesterol being
delivered to the inner membrane of mitochondria by StAR and StAR-related proteins. Here …

Anti-CD20 agents for multiple sclerosis: spotlight on ocrelizumab and ofatumumab

D Florou, M Katsara, J Feehan, E Dardiotis… - Brain Sciences, 2020 - mdpi.com
Until recently, in the pathogenesis of Multiple Sclerosis (MS), the contribution of B cells has
been largely underestimated, and the disease was considered a T-cell-mediated disorder …

MicroRNA alteration, application as biomarkers, and therapeutic approaches in neurodegenerative diseases

TPN Nguyen, M Kumar, E Fedele, G Bonanno… - International journal of …, 2022 - mdpi.com
MicroRNAs (miRNAs) are essential post-transcriptional gene regulators involved in various
neuronal and non-neuronal cell functions and play a key role in pathological conditions …

Cellular and molecular evidence of multiple sclerosis diagnosis and treatment challenges

Z Khan, GD Gupta, S Mehan - Journal of clinical medicine, 2023 - mdpi.com
Multiple sclerosis (MS) is a chronic autoimmune disease that impacts the central nervous
system and can result in disability. Although the prevalence of MS has increased in India …